Promentis Pharmaceuticals

Promentis Pharmaceuticals is a privately-held biopharmaceutical company that develops therapies for neuropsychiatric disorders, including its main product SXC-2023 aimed at treating trichotillomania

Biotech & Life Sciences

Sector

Seed

Stage

Biopharmaceutical

Model

01Company Overview

Promentis Pharmaceuticals is a privately-held biopharmaceutical company that develops therapies for neuropsychiatric disorders, including its main product SXC-2023 aimed at treating trichotillomania.

02Backed By1 investor

ACAisling Capital→

03Similar Companies